Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension

American Journal of Cardiology

Volumn 87, Issue 1, 2001, Pages 61-65

  Schussheim, Adam E ^a   Diamond, Joseph A ^a   Phillips, Robert A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL MOTION; HEART PERFORMANCE; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; NIFEDIPINE; PROGNOSIS; PROSPECTIVE STUDIES; VASODILATOR AGENTS; VERAPAMIL;

EID: 0035184765     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01273-X     Document Type: Article

References (24)

1. Assessment of left ventricular function by the midwall functional shortening/end-systolic stress relation in human hypertension
2. Left ventricular midwall mechanics in systemic arterial hypertension: Myocardial function is depressed in pressure-overload hypertrophy
3. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension
4. Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension
5. Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension
6. Cardiac performance after reduction of myocardial hypertrophy
7. Preserved ventricular pump function after a marked reduction of left ventricular mass
8. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril
9. Both a calcium antagonist and ACE inhibitor reverse hypertrophy in hypertension but a calcium antagonist also depresses contractility
10. Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients
11. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
12. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and of the impact of overweight
13. The committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M- mode echocardiography: Results of a survey of echocardiographic measurements
14. Interobserver variability of left ventricular measurements in a population of predominantly obese hypertensives using simultaneously acquired and displayed M-mode and 2D cine echocardiography
15. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques
16. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy
17. The role of hypertension in the pathogenesis of heart failure
18. Prognostic significance of serial changes in left ventricular mass in essential hypertension
19. Regression of left ventricular hypertrophy. How and why?
20. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure
21. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
22. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)
23. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989
24. Left ventricular hypertrophy in hypertension